STAAR Surgical Co
Open
SectorGezondheidszorg
28.66 1.09
Overzicht
Wijziging aandelenprijs
24u
Min
28.13
Max
28.7
Inkomsten | 5.2M 5.2M |
|---|---|
Verkoop | 36M 94M |
EPS | 0.1 |
Winstmarge | 5.567 |
Werknemers | 921 |
EBITDA | 28M 20M |
Aanbevelingen | Neutraal |
|---|---|
12 Maanden Prognose | +10.43% upside |
Volgende Winsten | 5 aug 2026 |
|---|
Marktkapitalisatie | 106M 1.5B |
|---|---|
Vorige openingsprijs | 27.57 |
Vorige sluitingsprijs | 28.66 |
Nieuwssentiment
By Acuity
38%
62%
102 / 342 Rangschikking in Healthcare
STAAR Surgical Co Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.